메뉴 건너뛰기




Volumn 20, Issue 40, 2014, Pages 6238-6248

Hypertriglyceridaemia, postprandial lipaemia and non-HDL cholesterol

Author keywords

High density lipoprotein; Low density lipoprotein cholesterol (LDL C); Non high density lipoprotein cholesterol; Postprandial hyperlipidaemia; Triglycerides

Indexed keywords

FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

EID: 84924621778     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140620120130     Document Type: Article
Times cited : (15)

References (160)
  • 1
    • 0002746856 scopus 로고
    • Serum triglycerides in coronary artery disease
    • Albrink MJ, Man EB, Serum triglycerides in coronary artery disease. Arch Intern Med 1959; 103: 4-8.
    • (1959) Arch Intern Med , vol.103 , pp. 4-8
    • Albrink, M.J.1    Man, E.B.2
  • 2
    • 0001630654 scopus 로고
    • Serum triglycerides in health and in ischemic heart disease
    • Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and in ischemic heart disease. N Engl J Med 1965; 273: 947-52.
    • (1965) N Engl J Med , vol.273 , pp. 947-952
    • Brown, D.F.1    Kinch, S.H.2    Doyle, J.T.3
  • 3
    • 0027065022 scopus 로고
    • Epidemiology of triglycerides. A view from Framingham
    • Castelli WP. Epidemiology of triglycerides. A view from Framingham. Am J Cardiol 1992; 70: 3H-9H.
    • (1992) Am J Cardiol , vol.70 , pp. 3H-9H
    • Castelli, W.P.1
  • 4
    • 0027924658 scopus 로고
    • Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease
    • NIH Consensus conference
    • NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA 1993; 269: 505-10.
    • (1993) JAMA , vol.269 , pp. 505-510
  • 5
    • 0029838433 scopus 로고    scopus 로고
    • Plasma triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: A meta-analysis of population-based prospective studies
    • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-9.
    • (1996) J Cardiovasc Risk , vol.3 , pp. 213-219
    • Hokanson, J.E.1    Austin, M.A.2
  • 6
    • 15944403233 scopus 로고    scopus 로고
    • Plasma triglycerides and Type III hyperlipidemia are independently associated with premature familial coronary artery disease
    • Hopkins PN, Wu LL, Hunt SC, Brinton EA. Plasma triglycerides and Type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol 2005; 45: 1003-12.
    • (2005) J am Coll Cardiol , vol.45 , pp. 1003-1012
    • Hopkins, P.N.1    Wu, L.L.2    Hunt, S.C.3    Brinton, E.A.4
  • 7
    • 0035806916 scopus 로고    scopus 로고
    • Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(A), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study
    • Atherosclerosis Risk in Communities Study Group
    • Sharrett AR, Ballantyne CM, Coady SA, et al. Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-13.
    • (2001) Circulation , vol.104 , pp. 1108-1113
    • Sharrett, A.R.1    Ballantyne, C.M.2    Coady, S.A.3
  • 8
    • 84866146620 scopus 로고    scopus 로고
    • Endocrine society Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline
    • Berglund L, Brunzell JD, Goldberg AC, et al. Endocrine society Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2969-89.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 2969-2989
    • Berglund, L.1    Brunzell, J.D.2    Goldberg, A.C.3
  • 9
    • 84875813175 scopus 로고    scopus 로고
    • Severe hypertriglyceridemiarelated acute pancreatitis
    • Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemiarelated acute pancreatitis. Ther Apher Dial 2013; 17: 130-7.
    • (2013) Ther Apher Dial , vol.17 , pp. 130-137
    • Stefanutti, C.1    Labbadia, G.2    Morozzi, C.3
  • 10
    • 84881381644 scopus 로고    scopus 로고
    • Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue
    • Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284.
    • (2013) J Clin Apher , vol.28 , Issue.3 , pp. 145-284
    • Schwartz, J.1    Winters, J.L.2    Padmanabhan, A.3    Balogun, R.A.4    Delaney, M.5    Linenberger, M.L.6    Szczepiorkowski, Z.M.7    Williams, M.E.8    Wu, Y.9    Shaz, B.H.10
  • 11
    • 84872172890 scopus 로고    scopus 로고
    • Treatment options for severe hypertriglyceridemia (SHTG): The role of apheresis
    • Ewald N, Kloer HU. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol 2012; (1)7: 315.
    • (2012) Clin Res Cardiol , vol.7 , Issue.1 , pp. 315
    • Ewald, N.1    Kloer, H.U.2
  • 13
    • 0036207653 scopus 로고    scopus 로고
    • Long-term followup of patients with acute hypertriglyceridemia-induced pancreatitis
    • Athyros VG, Giouleme OI, Nikolaidis NL, et al. Long-term followup of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002; 34: 4725.
    • (2002) J Clin Gastroenterol , vol.34 , pp. 4725
    • Athyros, V.G.1    Giouleme, O.I.2    Nikolaidis, N.L.3
  • 15
    • 79955582390 scopus 로고    scopus 로고
    • Assessment and Clinical Relevance of Non-Fasting and Postparandial Triglycerides: An Expert Panel Statement
    • Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and Clinical Relevance of Non-Fasting and Postparandial Triglycerides: An Expert Panel Statement. Curr Vas Pharmacol 2011; 9: 258-70.
    • (2011) Curr Vas Pharmacol , vol.9 , pp. 258-270
    • Kolovou, G.D.1    Mikhailidis, D.P.2    Kovar, J.3
  • 17
    • 0026354893 scopus 로고
    • Structure and metabolism of low density lipoproteins from normal and hypertriglyceridemic subjects
    • McKeone BJ, Patsch JR, Pownall HJ. Structure and metabolism of low density lipoproteins from normal and hypertriglyceridemic subjects. Adv Exp Med Biol 1991; 285: 289-93.
    • (1991) Adv Exp Med Biol , vol.285 , pp. 289-293
    • McKeone, B.J.1    Patsch, J.R.2    Pownall, H.J.3
  • 19
    • 0026480744 scopus 로고
    • Relation of triglyceride metabolism and coronary heart disease: Studies in the postprandial state
    • Patsch JR, Miesenbrock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary heart disease: studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
    • (1992) Arterioscler Thromb , vol.12 , pp. 1336-1345
    • Patsch, J.R.1    Miesenbrock, G.2    Hopferwieser, T.3
  • 20
    • 23244462620 scopus 로고    scopus 로고
    • Lipoprotein retention- and clues for atheroma regression
    • Williams KJ, Tabas I. Lipoprotein retention- and clues for atheroma regression. Arterioscler Thromb Vasc Biol 2005; 25: 1536-40.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1536-1540
    • Williams, K.J.1    Tabas, I.2
  • 21
    • 34447511196 scopus 로고    scopus 로고
    • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
    • Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 2007; 298: 299-308.
    • (2007) Jama , vol.298 , pp. 299-308
    • Nordestgaard, B.G.1    Benn, M.2    Schnohr, P.3    Tybjaerg-Hansen, A.4
  • 22
    • 33847055477 scopus 로고    scopus 로고
    • Improving prediction of ischemic cardiovascular disease in the general population usingapolipoprotein B: The Copenhagen City Heart Study
    • Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Improving prediction of ischemic cardiovascular disease in the general population usingapolipoprotein B: the Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 2007; 27: 661-70.
    • (2007) Arterioscler Thromb Vasc Biol , vol.27 , pp. 661-670
    • Benn, M.1    Nordestgaard, B.G.2    Jensen, G.B.3    Tybjaerg-Hansen, A.4
  • 23
    • 52149109922 scopus 로고    scopus 로고
    • Fasting compared with non-fastinglipids and apolipoproteins for predicting incident cardiovascular events
    • Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with non-fastinglipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008; 118: 993-1001.
    • (2008) Circulation , vol.118 , pp. 993-1001
    • Mora, S.1    Rifai, N.2    Buring, J.E.3    Ridker, P.M.4
  • 24
    • 0029741921 scopus 로고    scopus 로고
    • A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
    • Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-824
    • (1996) JAMA , vol.276 , pp. 882-824
    • Stampfer, M.J.1    Krauss, R.M.2    Ma, J.3
  • 25
    • 0029741921 scopus 로고    scopus 로고
    • A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
    • Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-8.
    • (1996) JAMA , vol.276 , pp. 882-888
    • Stampfer, M.J.1    Krauss, R.M.2    Ma, J.3
  • 26
    • 0027490520 scopus 로고
    • Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women
    • Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ 1993; 307: 1318-22.
    • (1993) BMJ , vol.307 , pp. 1318-1322
    • Stensvold, I.1    Tverdal, A.2    Urdal, P.3    Graff-Iversen, S.4
  • 27
    • 0037015288 scopus 로고    scopus 로고
    • Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short and long-term simvastatin treatment
    • Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short and long-term simvastatin treatment. Circulation 2002; 106: 1211-8.
    • (2002) Circulation , vol.106 , pp. 1211-1218
    • Ceriello, A.1    Taboga, C.2    Tonutti, L.3
  • 28
    • 0037126729 scopus 로고    scopus 로고
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
    • Third Report of the National Cholesterol Education Program (NCEP)
    • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 29
    • 0021703067 scopus 로고
    • Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects
    • Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 1984; 74: 2178-92.
    • (1984) J Clin Invest , vol.74 , pp. 2178-2192
    • Packard, C.J.1    Munro, A.2    Lorimer, A.R.3    Gotto, A.M.4    Shepherd, J.5
  • 30
    • 0005665079 scopus 로고
    • Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans
    • Stalenhoef AF, Malloy MJ, Kane JP, Havel RJ. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A 1984; 81: 1839-43.
    • (1984) Proc Natl Acad Sci U S A , vol.81 , pp. 1839-1843
    • Stalenhoef, A.F.1    Malloy, M.J.2    Kane, J.P.3    Havel, R.J.4
  • 32
    • 0027402281 scopus 로고
    • Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus
    • Frayn KN, Coppack SW, Humphreys SM, Clark ML, Evans RD. Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus. Metabolism 1993; 42: 504-10.
    • (1993) Metabolism , vol.42 , pp. 504-510
    • Frayn, K.N.1    Coppack, S.W.2    Humphreys, S.M.3    Clark, M.L.4    Evans, R.D.5
  • 33
    • 84910110212 scopus 로고    scopus 로고
    • The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
    • Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis J Cardiovasc Risk 2000; 7: 325-31.
    • (2000) J Cardiovasc Risk , vol.7 , pp. 325-331
    • Ginsberg, H.N.1    Huang, L.S.2
  • 34
    • 0028839110 scopus 로고    scopus 로고
    • Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans
    • Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest1995; 95: 158-66.
    • J Clin Invest1995 , vol.95 , pp. 158-166
    • Lewis, G.F.1    Uffelman, K.D.2    Szeto, L.W.3
  • 35
    • 0345396377 scopus 로고
    • Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia
    • Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 1983; 80: 1449-53.
    • (1983) Proc Natl Acad Sci U S A , vol.80 , pp. 1449-1453
    • Patsch, J.R.1    Karlin, J.B.2    Scott, L.W.3    Smith, L.C.4    Gotto, A.M.5
  • 36
    • 0021676332 scopus 로고
    • Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase
    • Patsch JR, Prasad S, Gotto AM, Bengtsson-Olivecrona G. Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase. J Clin Invest 1984; 74: 2017-23.
    • (1984) J Clin Invest , vol.74 , pp. 2017-2023
    • Patsch, J.R.1    Prasad, S.2    Gotto, A.M.3    Bengtsson-Olivecrona, G.4
  • 37
    • 0023160916 scopus 로고
    • High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
    • Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.
    • (1987) J Clin Invest , vol.80 , pp. 341-347
    • Patsch, J.R.1    Prasad, S.2    Gotto, A.M.3    Patsch, W.4
  • 38
    • 0028172766 scopus 로고
    • Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages
    • Lechleitner M, Hoppichler F, Föger B, Patsch JR. Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb 1994; 14: 1799-807.
    • (1994) Arterioscler Thromb , vol.14 , pp. 1799-1807
    • Lechleitner, M.1    Hoppichler, F.2    Föger, B.3    Patsch, J.R.4
  • 39
    • 0030058975 scopus 로고    scopus 로고
    • Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
    • Bjorkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996; 37: 76-86.
    • (1996) J Lipid Res , vol.37 , pp. 76-86
    • Bjorkegren, J.1    Packard, C.J.2    Hamsten, A.3
  • 40
    • 0030980480 scopus 로고    scopus 로고
    • Alterations of VLDL composition during alimentary lipemia
    • Björkegren J, Hamsten A, Milne RW, Karpe F. Alterations of VLDL composition during alimentary lipemia. J Lipid Res 1997; 38: 301-14.
    • (1997) J Lipid Res , vol.38 , pp. 301-314
    • Björkegren, J.1    Hamsten, A.2    Milne, R.W.3    Karpe, F.4
  • 41
    • 0027424585 scopus 로고
    • Relation of plasma levels and composition of apolipoprotein Bcontaining lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction
    • Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein Bcontaining lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88(1): 2180-9.
    • (1993) Circulation , vol.88 , Issue.1 , pp. 2180-2189
    • Tornvall, P.1    Båvenholm, P.2    Landou, C.3    De Faire, U.4    Hamsten, A.5
  • 42
    • 0027485431 scopus 로고
    • Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events
    • Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-70.
    • (1993) Circulation , vol.88 , pp. 2762-2770
    • Phillips, N.R.1    Waters, D.2    Havel, R.J.3
  • 43
    • 0028558979 scopus 로고
    • Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease
    • Hamsten A, Karpe F, Båvenholm P, Silveira A. Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. J Intern Med Suppl 1994; 736: 75-88.
    • (1994) J Intern Med Suppl , vol.736 , pp. 75-88
    • Hamsten, A.1    Karpe, F.2    Båvenholm, P.3    Silveira, A.4
  • 44
    • 0018649439 scopus 로고
    • Atherogenesis: A postprandial phenomenon
    • Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
    • (1979) Circulation , vol.60 , pp. 473-485
    • Zilversmit, D.B.1
  • 45
    • 0025898720 scopus 로고
    • Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease
    • Groot PHE, van Stiphout WAHJ, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscl Thromb 1991; 11: 653-62.
    • (1991) Arterioscl Thromb , vol.11 , pp. 653-662
    • Groot, P.1    Van Stiphout, W.2    Krauss, X.H.3
  • 46
    • 0034181352 scopus 로고    scopus 로고
    • Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: Relations to angiographically verified severity of coronary artery disease
    • Syvänne M. Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150: 167-177.
    • (2000) Atherosclerosis , vol.150 , pp. 167-177
    • Syvänne, M.1
  • 47
    • 0029597837 scopus 로고
    • Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women
    • Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995; 15: 2122-9.
    • (1995) Arterioscler Thromb Vasc Biol , vol.15 , pp. 2122-2129
    • Sharrett, A.R.1    Chambless, L.E.2    Heiss, G.3    Paton, C.C.4    Patsch, W.5
  • 48
    • 0036242230 scopus 로고    scopus 로고
    • Increased postprandial lipemia in patients with normolipidemic peripheral arterial disease
    • Lupattelli G, Pasqualini L, Siepi D, et al. Increased postprandial lipemia in patients with normolipidemic peripheral arterial disease. Am Heart J 2002; 143: 733-8.
    • (2002) Am Heart J , vol.143 , pp. 733-738
    • Lupattelli, G.1    Pasqualini, L.2    Siepi, D.3
  • 49
    • 0033578450 scopus 로고    scopus 로고
    • Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle aged men
    • Boquist S, Ruotolo G, Tang R, Björkegren J, Bond MG, de Faire U, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle aged men. Circulation 1999; 100: 723-8.
    • (1999) Circulation , vol.100 , pp. 723-728
    • Boquist, S.1    Ruotolo, G.2    Tang, R.3    Björkegren, J.4    Bond, M.G.5    De Faire, U.6
  • 50
    • 0033851157 scopus 로고    scopus 로고
    • Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes
    • Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000; 23: 1401-6.
    • (2000) Diabetes Care , vol.23 , pp. 1401-1406
    • Teno, S.1    Uto, Y.2    Nagashima, H.3
  • 51
    • 0023277789 scopus 로고
    • Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study
    • Simons LA, Dwyer T, Simons J, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65, 181-9.
    • (1987) Atherosclerosis , vol.65 , pp. 181-189
    • Simons, L.A.1    Dwyer, T.2    Simons, J.3
  • 52
    • 0025651990 scopus 로고
    • Postprandial lipaemia, fenofibrate and coronary artery disease
    • Simpson HS, Williamson CM, Olivecrona T, et al. Postprandial lipaemia, fenofibrate and coronary artery disease. Atherosclerosis 1990; 85: 193-202.
    • (1990) Atherosclerosis , vol.85 , pp. 193-202
    • Simpson, H.S.1    Williamson, C.M.2    Olivecrona, T.3
  • 54
    • 0028889579 scopus 로고
    • Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women
    • Ginsberg HN, Jones J, Blaner WS, et al. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1829-38.
    • (1995) Arterioscler Thromb Vasc Biol , vol.15 , pp. 1829-1838
    • Ginsberg, H.N.1    Jones, J.2    Blaner, W.S.3
  • 55
    • 0034181352 scopus 로고    scopus 로고
    • Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: Relations to angiographically verified severity of coronary artery disease
    • Mero N, Malmström R, Steiner G, Taskinen MR, Syvänne M. Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150: 167-77.
    • (2000) Atherosclerosis , vol.150 , pp. 167-177
    • Mero, N.1    Malmström, R.2    Steiner, G.3    Taskinen, M.R.4    Syvänne, M.5
  • 56
    • 0030564992 scopus 로고    scopus 로고
    • Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: A case-control study
    • Meyer E, Westerveld HT, de Ruyter-Meijstek FC, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis 1996; 124: 221-35.
    • (1996) Atherosclerosis , vol.124 , pp. 221-235
    • Meyer, E.1    Westerveld, H.T.2    De Ruyter-Meijstek, F.C.3
  • 57
    • 0032844477 scopus 로고    scopus 로고
    • Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women
    • Weintraub MS, Grosskopf I, Charach G, Eckstein N, Rubinstein A. Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women. Metabolism 1999; 48: 1193-6.
    • (1999) Metabolism , vol.48 , pp. 1193-1196
    • Weintraub, M.S.1    Grosskopf, I.2    Charach, G.3    Eckstein, N.4    Rubinstein, A.5
  • 59
    • 0028172762 scopus 로고
    • Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
    • Rapp JH, Lespine A, Hamilton RL, et al Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arter Thromb 1994; 14: 1767-74.
    • (1994) Arter Thromb , vol.14 , pp. 1767-1774
    • Rapp, J.H.1    Lespine, A.2    Hamilton, R.L.3
  • 60
    • 0032693599 scopus 로고    scopus 로고
    • Atherosclerosis is an inflammatory disease
    • Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: S419-20.
    • (1999) Am Heart J , vol.138 , pp. S419-SS20
    • Ross, R.1
  • 61
    • 84865485915 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis
    • Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 2045-51.
    • (2012) Arterioscler Thromb Vasc Biol , vol.32 , pp. 2045-2051
    • Libby, P.1
  • 62
    • 0029910844 scopus 로고    scopus 로고
    • In vivo demonstration in humans that large triglyceride rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway
    • Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large triglyceride rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 1996; 16: 1333-9.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 1333-1339
    • Silveira, A.1    Karpe, F.2    Johnsson, H.3    Bauer, K.A.4    Hamsten, A.5
  • 63
    • 0035992611 scopus 로고    scopus 로고
    • Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men
    • Hyson DA, Paglieroni TG, Wun T, Rutledge JC. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002, 8: 147-55.
    • (2002) Clin Appl Thromb Hemost , vol.8 , pp. 147-155
    • Hyson, D.A.1    Paglieroni, T.G.2    Wun, T.3    Rutledge, J.C.4
  • 64
    • 79956319051 scopus 로고    scopus 로고
    • Progress and challenges in translating the biology of atherosclerosis
    • Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473(7347): 317-25.
    • (2011) Nature , vol.473 , Issue.7347 , pp. 317-325
    • Libby, P.1    Ridker, P.M.2    Hansson, G.K.3
  • 66
    • 0029057589 scopus 로고
    • Insulin resistance and lipoprotein metabolism
    • Taskinen MR: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995; 6: 153-60.
    • (1995) Curr Opin Lipidol , vol.6 , pp. 153-160
    • Taskinen, M.R.1
  • 67
    • 3142729178 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
    • National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association
    • Grundy SM, Cleeman JL, Mercz CN. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-39.
    • (2004) Circulation , vol.110 , pp. 227-239
    • Grundy, S.M.1    Cleeman, J.L.2    Mercz, C.N.3
  • 68
    • 0024501678 scopus 로고
    • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
    • Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
    • (1989) Circulation , vol.79 , pp. 8-15
    • Gordon, D.J.1    Probstfield, J.L.2    Garrison, R.J.3
  • 69
    • 48549093490 scopus 로고    scopus 로고
    • National Lipid Association Taskforce on Non-HDL Cholesterol. The importance of non-HDL cholesterol reporting in lipid management
    • Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA. National Lipid Association Taskforce on Non-HDL Cholesterol. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol 2008; 2: 267-73.
    • (2008) J Clin Lipidol , vol.2 , pp. 267-273
    • Blaha, M.J.1    Blumenthal, R.S.2    Brinton, E.A.3    Jacobson, T.A.4
  • 70
    • 41249103856 scopus 로고    scopus 로고
    • Atherogenicity and Predictive Value of Non-High-Density Lipoprotein Cholesterol for Coronary Heart Disease
    • Miller M, et al. Atherogenicity and Predictive Value of Non-High-Density Lipoprotein Cholesterol for Coronary Heart Disease. Am J Cardiol 2008; 101: 1003-8.
    • (2008) Am J Cardiol , vol.101 , pp. 1003-1008
    • Miller, M.1
  • 71
    • 70450081001 scopus 로고    scopus 로고
    • Major lipids apolipoproteins, and risk of vascular disease
    • The Emerging Risk Factors Collaboration
    • The Emerging Risk Factors Collaboration. Major lipids apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000.
    • (2009) JAMA , vol.302 , pp. 1993-2000
  • 72
    • 21444438990 scopus 로고    scopus 로고
    • Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial
    • Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 56-65.
    • (2005) JAMA , vol.294 , pp. 56-65
    • Lee, I.M.1    Cook, N.R.2    Gaziano, J.M.3
  • 73
    • 0034912018 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
    • Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413-9.
    • (2001) Arch Intern Med , vol.161 , pp. 1413-1419
    • Cui, Y.1    Blumenthal, R.S.2    Flaws, J.A.3
  • 75
    • 0035897696 scopus 로고    scopus 로고
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult TreatmentPanel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult TreatmentPanel III). JAMA 2001; 285: 2486-97.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 76
    • 0038135048 scopus 로고    scopus 로고
    • Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A metaanalysis of 60 controlled trials
    • Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a metaanalysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-55.
    • (2003) Am J Clin Nutr , vol.77 , pp. 1146-1155
    • Mensink, R.P.1    Zock, P.L.2    Kester, A.D.3    Katan, M.B.4
  • 77
    • 18644362774 scopus 로고    scopus 로고
    • Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism
    • Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005; 63: 133-57.
    • (2005) Nutr Rev , vol.63 , pp. 133-157
    • Havel, P.J.1
  • 78
    • 0037042231 scopus 로고    scopus 로고
    • The glycemic index: Physiological mechanism relating to obesity, diabetes, and cardiovascular disease
    • Ludwig DS. The glycemic index: physiological mechanism relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287: 2414-23.
    • (2002) JAMA , vol.287 , pp. 2414-2423
    • Ludwig, D.S.1
  • 79
    • 0021821575 scopus 로고
    • The reduction of plasma lipids, lipoproteins, and apoproteins in hypertriglyceridemic patients by dietary fish oils
    • Phillipson BE, Totkrock DW, Connor WE, Harris WS, Illingworth DR. The reduction of plasma lipids, lipoproteins, and apoproteins in hypertriglyceridemic patients by dietary fish oils. N Engl J Med 1985; 312: 1210.
    • (1985) N Engl J Med , vol.312 , pp. 1210
    • Phillipson, B.E.1    Totkrock, D.W.2    Connor, W.E.3    Harris, W.S.4    Illingworth, D.R.5
  • 80
    • 69549088818 scopus 로고    scopus 로고
    • Omega-3 fatty acids for the treatment of elevated triglycerides
    • Maki KC, Dicklin MR, Lawless AL, Reeves MS. Omega-3 fatty acids for the treatment of elevated triglycerides. Clin Lipidol 2009; 4: 425-37.
    • (2009) Clin Lipidol , vol.4 , pp. 425-437
    • Maki, K.C.1    Dicklin, M.R.2    Lawless, A.L.3    Reeves, M.S.4
  • 81
    • 0345109256 scopus 로고    scopus 로고
    • Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico
    • GISSI-Prevenzione Investigators
    • GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999; 354: 447-55.
    • (1999) Lancet , vol.354 , pp. 447-455
  • 82
    • 0019181443 scopus 로고
    • Effect of controlled alcohol feeding on triglycerides in patients with outpatient’alcohol hypertriglyceridemia’
    • Erkelens DW, Brunzell JD. Effect of controlled alcohol feeding on triglycerides in patients with outpatient’alcohol hypertriglyceridemia’. J Hum Nutr 1980; 34: 370-5.
    • (1980) J Hum Nutr , vol.34 , pp. 370-375
    • Erkelens, D.W.1    Brunzell, J.D.2
  • 83
    • 77956652380 scopus 로고    scopus 로고
    • Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men
    • Dekker MJ, Graham TE, Ooi TC, Robinson LE. Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men. J Nutr Biochem 2010; 21: 983-90.
    • (2010) J Nutr Biochem , vol.21 , pp. 983-990
    • Dekker, M.J.1    Graham, T.E.2    Ooi, T.C.3    Robinson, L.E.4
  • 84
    • 69249219155 scopus 로고    scopus 로고
    • Resistance exercise plus to aerobic activities is associated with better lipid’s profile among healthy individuals: The ATTICA study
    • Pitsavos C, Panagiotakos DB, Tambalis KD, et al. Resistance exercise plus to aerobic activities is associated with better lipid’s profile among healthy individuals: the ATTICA study. QJM 2009; 102: 609-16.
    • (2009) QJM , vol.102 , pp. 609-616
    • Pitsavos, C.1    Panagiotakos, D.B.2    Tambalis, K.D.3
  • 85
    • 70349342714 scopus 로고    scopus 로고
    • Effects of fibrates on lipid profiles and cardiovascular outcomes: A systematic review
    • Albourbih S, Filion KB, Joseph I, et al. Effects of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med 2009; 122: 1-8.
    • (2009) Am J Med , vol.122 , pp. 1-8
    • Albourbih, S.1    Filion, K.B.2    Joseph, I.3
  • 86
    • 3142550830 scopus 로고    scopus 로고
    • Fibrates for the treatment of the metabolic syndrome
    • Maki KC. Fibrates for the treatment of the metabolic syndrome. Curr Atheroscler Rep 2004; 6: 45-51.
    • (2004) Curr Atheroscler Rep , vol.6 , pp. 45-51
    • Maki, K.C.1
  • 87
    • 28044452217 scopus 로고    scopus 로고
    • Effects on long–term fenofibrate therapy on cardiovascular event in 9795 people with type 2 diabetes mellitus (The FIELD study): Randomised controlled trial
    • Keech A, Simes RJ, Barter P, et al. Effects on long–term fenofibrate therapy on cardiovascular event in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-61.
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3
  • 88
    • 0031938673 scopus 로고    scopus 로고
    • Overview of fenofibrate
    • Packard CJ. Overview of fenofibrate. Eur Heart J 1998; 19: A62-A65.
    • (1998) Eur Heart J , vol.19 , pp. A62-A65
    • Packard, C.J.1
  • 89
    • 0036040929 scopus 로고    scopus 로고
    • Effects of fibrates on serum metabolic parameters
    • Elisaf M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin 2002; 18: 269-76.
    • (2002) Curr Med Res Opin , vol.18 , pp. 269-276
    • Elisaf, M.1
  • 90
    • 33645730513 scopus 로고    scopus 로고
    • Cardioprotective properties of fibrates: Which fibrate, which patients, what mechanism?
    • Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation 2006; 113: 1553-5.
    • (2006) Circulation , vol.113 , pp. 1553-1555
    • Barter, P.J.1    Rye, K.A.2
  • 91
    • 0023232216 scopus 로고
    • Helsinki Heart Study: Primary – prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary – prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237-45.
    • (1987) N Engl J Med , vol.317 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 92
    • 0026597808 scopus 로고
    • Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment
    • Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85: 37-45.
    • (1992) Circulation , vol.85 , pp. 37-45
    • Manninen, V.1    Tenkanen, L.2    Koskinen, P.3
  • 93
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study group
    • The Action to Control Cardiovascular Risk in Diabetes Study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 94
    • 77951704587 scopus 로고    scopus 로고
    • Effects of combination lipid therapy in type 2 diabetes mellitus
    • Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-74.
    • (2010) N Engl J Med , vol.362 , pp. 1563-1574
    • Ginsberg, H.N.1    Elam, M.B.2    Lovato, L.C.3
  • 95
    • 0034604225 scopus 로고    scopus 로고
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
    • The BIP Study Group
    • The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000; 102: 21-7.
    • (2000) Circulation , vol.102 , pp. 21-27
  • 96
    • 85048354213 scopus 로고    scopus 로고
    • Combination lipid therapy in type 2 diabetes
    • Sacks FM, Carey VJ, Fruchart JC. Combination lipid therapy in type 2 diabetes. N Engl J Med 2010; 363: 692-5.
    • (2010) N Engl J Med , vol.363 , pp. 692-695
    • Sacks, F.M.1    Carey, V.J.2    Fruchart, J.C.3
  • 97
    • 22644437126 scopus 로고    scopus 로고
    • Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review
    • Carlson IA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005; 258: 94-114.
    • (2005) J Intern Med , vol.258 , pp. 94-114
    • Carlson, I.A.1
  • 98
    • 73849123857 scopus 로고    scopus 로고
    • What’s the deal with niacin development: Is laropripanta dd-on therapy a winning strategy to beat a straight flush?
    • Bays HE, Ballantyne C. What’s the deal with niacin development: is laropripanta dd-on therapy a winning strategy to beat a straight flush? Curr Opin Lipidol 2009; 20: 467-76.
    • (2009) Curr Opin Lipidol , vol.20 , pp. 467-476
    • Bays, H.E.1    Ballantyne, C.2
  • 99
    • 34548190309 scopus 로고    scopus 로고
    • Lipid-lowering agents that cause druginduced hepatotoxicity
    • Bhardwaj SS, Chalasani N. Lipid-lowering agents that cause druginduced hepatotoxicity. Clin Liver Dis 2007; 11: 597-613.
    • (2007) Clin Liver Dis , vol.11 , pp. 597-613
    • Bhardwaj, S.S.1    Chalasani, N.2
  • 100
    • 18844401094 scopus 로고    scopus 로고
    • Nicotinic acid in the management of dyslipidemia associated with diabetes and metabolic syndrome: A position paper developed by European Consensus Panel
    • Shepherd J, Betteridge J, Van Gaal L. Nicotinic acid in the management of dyslipidemia associated with diabetes and metabolic syndrome: a position paper developed by European Consensus Panel. Curr Med Res Opin 2005; 21: 665-82.
    • (2005) Curr Med Res Opin , vol.21 , pp. 665-682
    • Shepherd, J.1    Betteridge, J.2    Van Gaal, L.3
  • 101
    • 0035969564 scopus 로고    scopus 로고
    • Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
    • Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-92.
    • (2001) N Engl J Med , vol.345 , pp. 1583-1592
    • Brown, B.G.1    Zhao, X.Q.2    Chait, A.3
  • 102
    • 84855171302 scopus 로고    scopus 로고
    • Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
    • Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011; 365: 2255-67.
    • (2011) N Engl J Med , vol.365 , pp. 2255-2267
    • Boden, W.E.1    Probstfield, J.L.2    Erson, T.3
  • 103
    • 0842324675 scopus 로고    scopus 로고
    • Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
    • Zhao XQ, Morse JS, Dowdy AA, et al. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Am J Cardiol 2004; 93: 307-12.
    • (2004) Am J Cardiol , vol.93 , pp. 307-312
    • Zhao, X.Q.1    Morse, J.S.2    Dowdy, A.A.3
  • 104
    • 77953121328 scopus 로고    scopus 로고
    • Treatment Strategies in Atherosclerosis): Final results and the impact of medication adherence, dose, and treatment duration
    • The ARBITER 6-HALTS TRIAL (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6 HDL and LDL
    • Villines TC, Stanek EJ, Devine PJ, et al. The ARBITER 6-HALTS TRIAL (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6 HDL and LDL. Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 2010; 55: 2721-6.
    • (2010) J am Coll Cardiol , vol.55 , pp. 2721-2726
    • Villines, T.C.1    Stanek, E.J.2    Devine, P.J.3
  • 105
    • 70349742488 scopus 로고    scopus 로고
    • Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
    • Davidson MH, Maki KC, Bays H, et al. Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol 2009; 3: 332-40.
    • (2009) J Clin Lipidol , vol.3 , pp. 332-340
    • Davidson, M.H.1    Maki, K.C.2    Bays, H.3
  • 106
    • 77953670912 scopus 로고    scopus 로고
    • Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides
    • Musa-Veloso K, Binns MA, Kocenas AC, et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010; 68: 155-67.
    • (2010) Nutr Rev , vol.68 , pp. 155-167
    • Musa-Veloso, K.1    Binns, M.A.2    Kocenas, A.C.3
  • 107
    • 77956635797 scopus 로고    scopus 로고
    • Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering
    • Maki KC, Rains TM. Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering. Nutr Rev 2010; 68: 567-8.
    • (2010) Nutr Rev , vol.68 , pp. 567-568
    • Maki, K.C.1    Rains, T.M.2
  • 108
    • 79251509572 scopus 로고    scopus 로고
    • Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy person with moderate hypertriglyceridemia
    • Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy person with moderate hypertriglyceridemia. Am J Clin Nutr 2011; 93: 243-52.
    • (2011) Am J Clin Nutr , vol.93 , pp. 243-252
    • Skulas-Ray, A.C.1    Kris-Etherton, P.M.2    Harris, W.S.3
  • 109
    • 33947601804 scopus 로고    scopus 로고
    • Prescription omega-3 fatty acids from the treatment of hypertriglyceridemia
    • McKenney JM, Sica D. Prescription omega-3 fatty acids from the treatment of hypertriglyceridemia. Am J Health Syst Pharm 2007; 64: 595-605.
    • (2007) Am J Health Syst Pharm , vol.64 , pp. 595-605
    • McKenney, J.M.1    Sica, D.2
  • 110
    • 84889686400 scopus 로고    scopus 로고
    • Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study
    • Tatsuno I, Saito Y, Kudou K, Ootake J. Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study. J Clin Lipidol 2013; 7: 615-25.
    • (2013) J Clin Lipidol , vol.7 , pp. 615-625
    • Tatsuno, I.1    Saito, Y.2    Kudou, K.3    Ootake, J.4
  • 111
    • 49749128376 scopus 로고    scopus 로고
    • Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
    • for the JELIS Investigators, Japan
    • Saito Y, Yokoyama M, Origasa H, et al. for the JELIS Investigators, Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008; 200: 135-40.
    • (2008) Atherosclerosis , vol.200 , pp. 135-140
    • Saito, Y.1    Yokoyama, M.2    Origasa, H.3
  • 112
    • 0042512336 scopus 로고    scopus 로고
    • European Guidelines on Cardiovascular Disease Prevention in Clinical Practice
    • Third Joint Task Force of European and Other Societies on Cardiovascular Prevention in Clinical PRACTICE
    • De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Third Joint Task Force of European and Other Societies on Cardiovascular Prevention in Clinical PRACTICE. Eur Heart J 2003; 24: 1601-10.
    • (2003) Eur Heart J , vol.24 , pp. 1601-1610
    • De Backer, G.1    Ambrosioni, E.2    Borch-Johnsen, K.3
  • 113
    • 72649096155 scopus 로고    scopus 로고
    • Severe hypertriglyceridemia: An indication for apheresis?
    • Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 2009; 10: 49-52.
    • (2009) Atheroscler Suppl , vol.10 , pp. 49-52
    • Ewald, N.1    Kloer, H.U.2
  • 114
    • 84872834801 scopus 로고    scopus 로고
    • A three month-old infant with severe hyperchylomicronemia: Molecular diagnosis and extracorporeal treatment
    • Stefanutti C, Gozzer M, Pisciotta L, et al. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. Atheroscler Suppl 2013; 14: 73-6.
    • (2013) Atheroscler Suppl , vol.14 , pp. 73-76
    • Stefanutti, C.1    Gozzer, M.2    Pisciotta, L.3
  • 115
    • 8744220574 scopus 로고    scopus 로고
    • Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis
    • Iskandar SB, Olive KE. Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis. Am J Med Sci 2004; 328: 290-4.
    • (2004) Am J Med Sci , vol.328 , pp. 290-294
    • Iskandar, S.B.1    Olive, K.E.2
  • 116
    • 84860415876 scopus 로고    scopus 로고
    • Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis
    • Stefanutti C, Di Giacomo S, Labbadia G. Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis. Transfus Apher Sci 2011; 45: 3-7.
    • (2011) Transfus Apher Sci , vol.45 , pp. 3-7
    • Stefanutti, C.1    Di Giacomo, S.2    Labbadia, G.3
  • 117
    • 74049160452 scopus 로고    scopus 로고
    • Therapeutic plasma Exchange in patients with severe hypertrygliceridemia: A multicenter study
    • Stefanutti C, Di Giacomo S, Vivenzio A, et al. Therapeutic plasma Exchange in patients with severe hypertrygliceridemia: a multicenter study. Artif Organs 2009; 33: 1096-102.
    • (2009) Artif Organs , vol.33 , pp. 1096-1102
    • Stefanutti, C.1    Di Giacomo, S.2    Vivenzio, A.3
  • 118
    • 65449123928 scopus 로고    scopus 로고
    • Dyslipidemic pancreatitis clinical assessment and analysis of disease severity and outcomes
    • Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancrteatology 2009; 9: 252-7.
    • (2009) Pancrteatology , vol.9 , pp. 252-257
    • Erson, F.1    Thomson, S.R.2    Clarke, D.L.3    Buccimazza, I.4
  • 119
    • 44349124449 scopus 로고    scopus 로고
    • Therapeutic plasma exchangefor acute hyperlipidemic pancreatitis: A case series
    • Al-Humoud H, Alhumoud E, Al-Hilali N. Therapeutic plasma exchangefor acute hyperlipidemic pancreatitis: a case series. Ther Apher Dial 2008; 12: 202-4.
    • (2008) Ther Apher Dial , vol.12 , pp. 202-204
    • Al-Humoud, H.1    Alhumoud, E.2    Al-Hilali, N.3
  • 121
    • 79960205374 scopus 로고    scopus 로고
    • ESC/EAS guidelines for the management of dyslipidemia. The Task Force for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • European Society of Cardiology (ESC): European Atherosclerosis Society (EAS)
    • Catapano AL, Reiner Z, De Backer G, et al. European Society of Cardiology (ESC): European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidemia. The Task Force for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217: 3-46.
    • (2011) Atherosclerosis , vol.217 , pp. 3-46
    • Catapano, A.L.1    Reiner, Z.2    De Backer, G.3
  • 122
    • 85027956925 scopus 로고    scopus 로고
    • Triglyceridesand cardiovascular disease: A scientific statement from the American Heart Association
    • American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease
    • Miller M, Stone NJ, Ballantyne C, et al. American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglyceridesand cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292-333.
    • (2011) Circulation , vol.123 , pp. 2292-2333
    • Miller, M.1    Stone, N.J.2    Ballantyne, C.3
  • 123
    • 69249212383 scopus 로고    scopus 로고
    • Dyslipidemia and cardiovascular risk: The importance of early prevention
    • Miller M. Dyslipidemia and cardiovascular risk: the importance of early prevention. QJM 2009; 102(9): 657-67.
    • (2009) QJM , vol.102 , Issue.9 , pp. 657-667
    • Miller, M.1
  • 124
    • 84884995326 scopus 로고    scopus 로고
    • High-density lipoproteins: A consensus statement from the National Lipid Association
    • Toth PP, Barter PJ, Rosenson RS, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol 2013; 7: 484-525.
    • (2013) J Clin Lipidol , vol.7 , pp. 484-525
    • Toth, P.P.1    Barter, P.J.2    Rosenson, R.S.3
  • 125
    • 78049316310 scopus 로고    scopus 로고
    • Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?
    • Rana JS, Boekholdt SM. Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol? Curr Opin Cardiol 2010; 25: 622-6.
    • (2010) Curr Opin Cardiol , vol.25 , pp. 622-626
    • Rana, J.S.1    Boekholdt, S.M.2
  • 126
    • 33846639147 scopus 로고    scopus 로고
    • Value of lowdensity lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: The EPIC-Norfolk Prospective Population Study
    • El Harchaoui K, van der Steeg WA, Stroes ES, et al. Value of lowdensity lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 49(5): 547-53.
    • (2007) J am Coll Cardiol , vol.49 , Issue.5 , pp. 547-553
    • El Harchaoui, K.1    Van Der Steeg, W.A.2    Stroes, E.S.3
  • 127
    • 79955595080 scopus 로고    scopus 로고
    • Diagnostic value of postprandial triglyceride testing in healthy subjects: A metaanalysis
    • Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a metaanalysis. Curr Vasc Pharmacol 2011; 9: 271-80.
    • (2011) Curr Vasc Pharmacol , vol.9 , pp. 271-280
    • Mihas, C.1    Kolovou, G.D.2    Mikhailidis, D.P.3
  • 130
    • 84892366435 scopus 로고    scopus 로고
    • Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
    • Nov 26. pii: S0163-7258(13)00226-X, [Epub ahead of print] PubMed PMID: 24287311
    • Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther 2013 Nov 26. pii: S0163-7258(13)00226-X. doi: 10.1016/j.pharmthera2013.11.008. [Epub ahead of print] PubMed PMID: 24287311.
    • (2013) Pharmacol Ther
    • Varbo, A.1    Benn, M.2    Nordestgaard, B.G.3
  • 131
    • 84876175810 scopus 로고    scopus 로고
    • Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
    • Jørgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J 2013; 34: 1826-33.
    • (2013) Eur Heart J , vol.34 , pp. 1826-1833
    • Jørgensen, A.B.1    Frikke-Schmidt, R.2    West, A.S.3    Grande, P.4    Nordestgaard, B.G.5    Tybjærg-Hansen, A.6
  • 133
    • 79955583131 scopus 로고    scopus 로고
    • Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol
    • Nordestgaard BG, Freiberg JJ. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 2011; 9: 281-6.
    • (2011) Curr Vasc Pharmacol , vol.9 , pp. 281-286
    • Nordestgaard, B.G.1    Freiberg, J.J.2
  • 134
    • 79959356255 scopus 로고    scopus 로고
    • Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: The Copenhagen City Heart Study with 31 years of follow-up
    • Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011; 270: 65-75.
    • (2011) J Intern Med , vol.270 , pp. 65-75
    • Langsted, A.1    Freiberg, J.J.2    Tybjaerg-Hansen, A.3    Schnohr, P.4    Jensen, G.B.5    Nordestgaard, B.G.6
  • 135
    • 79952214780 scopus 로고    scopus 로고
    • Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study
    • Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2011; 57: 482-9.
    • (2011) Clin Chem , vol.57 , pp. 482-489
    • Langsted, A.1    Nordestgaard, B.G.2
  • 136
    • 84891601001 scopus 로고    scopus 로고
    • Effect of fructose on postprandial triglycerides: A systematic review and metaanalysis of controlled feeding trials
    • David Wang D, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on postprandial triglycerides: A systematic review and metaanalysis of controlled feeding trials. Atherosclerosis 2014; 232(1): 125-33.
    • (2014) Atherosclerosis , vol.232 , Issue.1 , pp. 125-133
    • David Wang, D.1    Sievenpiper, J.L.2    De Souza, R.J.3
  • 137
    • 24044513689 scopus 로고    scopus 로고
    • Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods
    • Nawawi HM, Yazid TN, Ismail F, Khalid BA. Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods. Asia Pac J Clin Nutr 2000; 9: 41-5.
    • (2000) Asia Pac J Clin Nutr , vol.9 , pp. 41-45
    • Nawawi, H.M.1    Yazid, T.N.2    Ismail, F.3    Khalid, B.A.4
  • 138
    • 84893751761 scopus 로고    scopus 로고
    • Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men
    • Kakuda H, Kobayashi J, Nakato M, Takekoshi N. Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men. Cholesterol 2013; 2013: 314170.
    • (2013) Cholesterol , vol.2013
    • Kakuda, H.1    Kobayashi, J.2    Nakato, M.3    Takekoshi, N.4
  • 139
    • 84964194240 scopus 로고    scopus 로고
    • Early Improvement of Postprandial Lipemia After Bariatric Surgery in Obese Type 2 Diabetic Patients
    • Dec 30. [Epub ahead of print] PubMed PMID: 24374941
    • Griffo E, Nosso G, Lupoli R, et al. Early Improvement of Postprandial Lipemia After Bariatric Surgery in Obese Type 2 Diabetic Patients. Obes Surg 2013 Dec 30. [Epub ahead of print] PubMed PMID: 24374941.
    • (2013) Obes Surg
    • Griffo, E.1    Nosso, G.2    Lupoli, R.3
  • 140
    • 84893514120 scopus 로고    scopus 로고
    • Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis inpatients with type 2 diabetes
    • Dec 27. pii: S0009-8981(13)00517-2
    • Idei M, Hirayama S, Miyake N, et al. Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis inpatients with type 2 diabetes. Clin Chim Acta 2013 Dec 27. pii: S0009-8981(13)00517-2. doi: 10.1016/j.cca 2013.12.022. [Epub ahead of print].
    • (2013) Clin Chim Acta
    • Idei, M.1    Hirayama, S.2    Miyake, N.3
  • 141
    • 84926066475 scopus 로고    scopus 로고
    • Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: A randomized controlled trial
    • Dec 24. [Epub ahead of print] PubMed PMID: 24368433
    • Annuzzi G, Bozzetto L, Costabile G, et al. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. Am J Clin Nutr 2013 Dec 24. [Epub ahead of print] PubMed PMID: 24368433.
    • (2013) Am J Clin Nutr
    • Annuzzi, G.1    Bozzetto, L.2    Costabile, G.3
  • 142
    • 84890530969 scopus 로고    scopus 로고
    • Diurnal triglyceridemia in relation to alcohol intake in men
    • Torres do Rego A, Klop B, Birnie E, et al. Diurnal triglyceridemia in relation to alcohol intake in men. Nutrients 2013; 5(12): 5114-26.
    • (2013) Nutrients , vol.5 , Issue.12 , pp. 5114-5126
    • Torres Do Rego, A.1    Klop, B.2    Birnie, E.3
  • 143
    • 84899909678 scopus 로고    scopus 로고
    • SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus
    • Dec 13, [Epub ahead of print]
    • Hassing HC, Surendran RP, Derudas B, et al. SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus. Obesity (Silver Spring) 2013 Dec 13. doi: 10.1002/oby20682. [Epub ahead of print].
    • (2013) Obesity (Silver Spring)
    • Hassing, H.C.1    Surendran, R.P.2    Derudas, B.3
  • 144
    • 84964194233 scopus 로고    scopus 로고
    • The glycemic/ metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus
    • Dec 13. [Epub ahead of print]
    • Ono Y, Nakamura A, Yong Cho K, Nomoto H. The glycemic/ metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus. Expert Opin Pharmacother 2013 Dec 13. [Epub ahead of print].
    • (2013) Expert Opin Pharmacother
    • Ono, Y.1    Nakamura, A.2    Yong Cho, K.3    Nomoto, H.4
  • 145
    • 84894274848 scopus 로고    scopus 로고
    • Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
    • Matikainen N, Burza MA, Romeo S, et al. Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects. PLoS One 2013 20; (11): e79473.
    • (2013) Plos One , vol.20 , Issue.11
    • Matikainen, N.1    Burza, M.A.2    Romeo, S.3
  • 146
    • 84887533343 scopus 로고    scopus 로고
    • The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/ macrophage cells
    • Varela LM, Ortega-Gomez A, Lopez S, Abia R, Muriana FJ, Bermudez B. The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/ macrophage cells. J Nutr Biochem 2013; 24(12): 2031-9.
    • (2013) J Nutr Biochem , vol.24 , Issue.12 , pp. 2031-2039
    • Varela, L.M.1    Ortega-Gomez, A.2    Lopez, S.3    Abia, R.4    Muriana, F.J.5    Bermudez, B.6
  • 147
    • 84872516435 scopus 로고    scopus 로고
    • Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
    • Samson CE, Galia AL, Llave KI, Zacarias MB, Mercado-Asis LB. Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment. Int J Endocrinol Metab 2012; 10(4): 587-93.
    • (2012) Int J Endocrinol Metab , vol.10 , Issue.4 , pp. 587-593
    • Samson, C.E.1    Galia, A.L.2    Llave, K.I.3    Zacarias, M.B.4    Mercado-Asis, L.B.5
  • 148
    • 84882710903 scopus 로고    scopus 로고
    • The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus
    • Sharifi F, Hojeghani N, Mazloomzadeh S, Shajari Z. The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus. J Diabetes Metab Disord 2013; 12(1): 24.
    • (2013) J Diabetes Metab Disord , vol.12 , Issue.1 , pp. 24
    • Sharifi, F.1    Hojeghani, N.2    Mazloomzadeh, S.3    Shajari, Z.4
  • 149
    • 84885300888 scopus 로고    scopus 로고
    • Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over trial
    • Hermansen K, Baekdal TA, Düring M, et al. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial. Diabetes Obes Metab 2013; 15(11): 1040-8.
    • (2013) Diabetes Obes Metab , vol.15 , Issue.11 , pp. 1040-1048
    • Hermansen, K.1    Baekdal, T.A.2    Düring, M.3
  • 150
    • 84920063295 scopus 로고    scopus 로고
    • Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study
    • Kojima Y, Kaga H, Hayashi S, et al. Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study. World J Diabetes 2013; 4: 8-13.
    • (2013) World J Diabetes , vol.4 , pp. 8-13
    • Kojima, Y.1    Kaga, H.2    Hayashi, S.3
  • 151
    • 84872020915 scopus 로고    scopus 로고
    • Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: A preliminary report
    • Noda Y, Miyoshi T, Oe H, et al. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: a preliminary report. Cardiovasc Diabetol 2013; 12: 8.
    • (2013) Cardiovasc Diabetol , vol.12 , pp. 8
    • Noda, Y.1    Miyoshi, T.2    Oe, H.3
  • 152
    • 84878047441 scopus 로고    scopus 로고
    • The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes
    • Matikainen N, Taskinen MR. The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes. Diabet Med 2013; 30(6): 756-7.
    • (2013) Diabet Med , vol.30 , Issue.6 , pp. 756-757
    • Matikainen, N.1    Taskinen, M.R.2
  • 153
    • 84873823647 scopus 로고    scopus 로고
    • Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial
    • Reyes-Soffer G, Ngai CI, Lovato L, et al. Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial. Diabetes Care 2013; 36(2): 422-8.
    • (2013) Diabetes Care , vol.36 , Issue.2 , pp. 422-428
    • Reyes-Soffer, G.1    Ngai, C.I.2    Lovato, L.3
  • 154
    • 84873023759 scopus 로고    scopus 로고
    • GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: Evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states
    • Hein GJ, Baker C, Hsieh J, Farr S, Adeli K. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes 2013; 62(2): 373-81.
    • (2013) Diabetes , vol.62 , Issue.2 , pp. 373-381
    • Hein, G.J.1    Baker, C.2    Hsieh, J.3    Farr, S.4    Adeli, K.5
  • 155
    • 84868619241 scopus 로고    scopus 로고
    • Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load
    • Hiramitsu S, Miyagishima K, Ishii J, et al. Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load. J Cardiol 2012; 60: 395-400.
    • (2012) J Cardiol , vol.60 , pp. 395-400
    • Hiramitsu, S.1    Miyagishima, K.2    Ishii, J.3
  • 156
    • 84871738435 scopus 로고    scopus 로고
    • Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia
    • Kikuchi K, Nezu U, Inazumi K, et al. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. J Atheroscler Thromb 2012; 19: 1093-101.
    • (2012) J Atheroscler Thromb , vol.19 , pp. 1093-1101
    • Kikuchi, K.1    Nezu, U.2    Inazumi, K.3
  • 157
    • 84868563102 scopus 로고    scopus 로고
    • Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia
    • Kostapanos MS, Elisaf MS, Mikhailidis DP. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia. J Cardiovasc Pharmacol Ther 2012; 17(4): 427.
    • (2012) J Cardiovasc Pharmacol Ther , vol.17 , Issue.4 , pp. 427
    • Kostapanos, M.S.1    Elisaf, M.S.2    Mikhailidis, D.P.3
  • 158
    • 84860504570 scopus 로고    scopus 로고
    • Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance
    • Naples M, Baker C, Lino M, Iqbal J, Hussain MM, Adeli K. Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance. Am J Physiol Gastrointest Liver Physiol 2012; 302(9): G1043-52.
    • (2012) Am J Physiol Gastrointest Liver Physiol , vol.302 , Issue.9 , pp. G1043-G1G52
    • Naples, M.1    Baker, C.2    Lino, M.3    Iqbal, J.4    Hussain, M.M.5    Adeli, K.6
  • 159
    • 79960698721 scopus 로고    scopus 로고
    • Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
    • Yunoki K, Nakamura K, Miyoshi T, et al. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis 2011; 217: 486-91.
    • (2011) Atherosclerosis , vol.217 , pp. 486-491
    • Yunoki, K.1    Nakamura, K.2    Miyoshi, T.3
  • 160
    • 79960230767 scopus 로고    scopus 로고
    • Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
    • Bozzetto L, Annuzzi G, Corte GD, et al. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. Atherosclerosis 2011; 217(1): 142-8.
    • (2011) Atherosclerosis , vol.217 , Issue.1 , pp. 142-148
    • Bozzetto, L.1    Annuzzi, G.2    Corte, G.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.